As a behavioural measure of performance, reaction time (RT) has the virtue of being readily and objectively determined as well as scaled in physical units. Moreover, a century of intensive psychological investigation of RT has led to the identification of a broad range of task variables capable of exercising systematic effects on RT, together with a better understanding of the cognitive and motor processes that intervene between stimulus and response. ' A major focus of neuropsychological interest has been the search for task-specific impairments which might be informative about underlying deficits. To this end, many studies have compared classic simple RT (SRT), in which a single stimulus is repeatedly used to elicit an unvarying, predefined response with binary choice RT (2CRT), in which alternative responses have been assigned to each of a pair of stimuli, so that stimulus presentation not only serves as the temporal cue to respond but specifies which response is required.
Studies of the effects of dopaminergic medication on reaction times in Parkinson's disease have generally failed to satisfy the elementary canons of pharmacological research, either in their procedure for selecting subjects or in their experimental design. In the typical study, five to eight patients have been selected from the extremely heterogeneous parkinsonian population and investigated using a simple within subjects experimental design. Many studies have failed to control order of testing effects by the inclusion of counterbalancing or by additional control groups.
The relative insensitivity of RT measures to medication status in previous studies of Parkinson's disease led us to seek a way of increasing the demands made upon the subject's ability to sustain a high rate of response initiation. Various strands of evidence suggest that the execution of a response by patients with Parkinson's disease is much more likely to be impaired if it forms an element in a composite. For example, in a task merely requiring transfer of gaze to a novel target, the kinematics of the saccade appear normal in mild to moderate Parkinson's disease. Under instruction to respond with a series of saccades reciprocating between target and central fixation, the first saccade-notwithstanding its elicitation by an identical stimulus-takes much longer even for controls to initiate. Not only is this effect greater in patients with Parkinson's disease, the accuracy of their saccade is also very abnormal. ' We determined the absence of reliable differences between the performance of fully medicated patients with mild to moderate Parkinson's disease and normal healthy controls by subjecting the latencies of the PD:C and normal age matched control groups on both sessions to ANOVA. Again, neither the main effect of group (F < 1) nor any interaction involving the group factor were significant. In particular, the slight reduction in latency across the two sessions (10 ms for PD:Cs and 12 ms for normal age matched controls) showed no differential tendency towards improvement (F < 1).
With this as a basis, we were able to proceed to our principal test, comparing the performance of the two Parkinson's disease groups in session 1 when the experimental group were off medication and in session 2 when their medication had been restored. The ANOVA disclosed a significant interaction of group, session, and response-stimulus intervals (F (6,84) = 2-22, P < 0-05). Figure 3 illustrates this. The source of this interaction seems to be the withdrawal of medication since it consists of a difference in performance which sets the PD:E group apart from the other groups only in session 1, when they were unmedicated. The effect consists of a latency prolongation, confined to the briefer response-stimulus intervals. Withdrawal of medication seems to exaggerate the normal tendency for latencies to increase, as if the subject requires some time to "recover" from the previous response. This "refractoriness" seemed to be abnormally increased by dopamine depletion.
We 
An alternative interpretation of the competition between overlapping processes which gives rise to refractoriness involves a shift of emphasis from the lingering traces of perceptuocognitive activity on trial Ti to the benefits to be gained when the subject is allowed to devote sufficient time and undivided attention to preparation in advance for T2. A version of this account which locates this preparation towards the response end of the processing cascade and consequently declines to regard refractoriness as exclusively attached to CRT, has been advanced by Rabbitt.20 His thesis is that refractoriness is caused by interference of response 1 with the response preparation for T2, on which optimal RT depends. Such an account is vulnerable to any demonstration of a dissociation between the function describing improvement in RT with increasing foreperiod (warning interval) and the function showing recovery of RT with increases in response-stimulus interval. Wilkinson19 has proposed sleep deprivation as such a dissociating factor, as it changes the form of the preparation function, but not the refractoriness function. Whereas neither the manipulation of informative precues that reduce some of the subject's uncertainties about the required response nor manipulations of the timing of a warning signal which serves a general alerting function have allowed the identification of a defect of preparation in Parkinson's disease, studies of the ability to capitalise on the certitudes that are peculiar to the SRT task have suggested that this aspect of preparation is defective in a subset of patients with Parkinson's disease. 2' In the present data, the undiminished magnitude of the refractoriness found in simple, as opposed to choice, RT is inconsistent with an interpretation of refractoriness in terms of central processes of stimulus discrimination or response selection. On the other hand, the failure to find greater refractoriness in CRT on trials in which the response is the same as that executed on the previous trial, seems to rule out an account in terms of limitations on response rate located at the effector level. The overall tendency in our CRT data towards briefer latencies on alternations than on repetitions seems most likely to be the result of a strategic bias induced by the time pressure of the refractoriness paradigm as in standard paradigms repetition has been widely found to be facilitatory.
What emerges from these considerations is the complexity of the issues surrounding preparation for rapid action. To the extent that refractoriness is interpretable as interference with preparation, the present experiment suggests that the process involved is vulnerable to levodopa withdrawal in Parkinson's disease and that this sensitivity might be greater in the SRT task. A quite separate strand of evidence suggests that some members of the parkinsonian population have lost the ability to engage in whatever preparations normally give SRT its latency advantage over high compatibility 2CRT. 21 Recently, moreover, the finding that transcranial magnetic stimulation of motor cortex can reduce the abnormal prolongation of RT sometimes found in patients with Parkinson's disease.22 2' has provided quite a different sort of basis for inferring defective preparation. Because yet other paradigms have been used to argue for the intactness of (some) preparatory processes in Parkinson's disease, it remains to be seen whether these differences in findings across the range of paradigms are consistently found and if so how successfully they can be interpreted in terms of functionally distinct aspects of preparation for rapid action. Certainly, the studies have differed in regard to the impairments the subjects have brought to the experiment. Whereas the excessive refractoriness revealed by medication withdrawal in this study was obtained for patients with Parkinson's disease who showed no signs of RT abnormality when properly medicated, to demonstrate the absence of SRT advantage clearly entails abnormally prolonged SRT. Finally, in as much as the transcranial magnetic stimulation studies focus on the return of SRT and CRT to normality, an initial deficit in one or the other is presupposed.
RT AS A MARKER FOR AKINESIA
It is evident from the present results that RT conditions which are demonstrably capable of showing significant effects of medication withdrawal may nevertheless fail to discriminate the performance of fully medicated patients with Parkinson's disease from controls. Pooling the session 2 data for both Parkinson's disease groups, their overall mean RT (n = 16) exceeded that of the control group (n = 8) by a mere 4 ms. Others have reported RTs in mild cases that are slightly but not significantly faster than controls.24 It seems incontestable, therefore, that, within the sort of mild-to-moderately impaired population of patients with Parkinson's disease that we have preferred to study, individuals can readily be found whose mean keypress RT, based on an adequate number of observations, lies consistently well within normal bounds. We say "consistently" to emphasise that the individuals who are found to satisfy these criteria do not comprise an ever changing set that arise as the ephemeral products of random error variance; each subject in the present study generated about 800 RT observations. Nor can this apparent normality be dismissed as a consequence of insensitive methods of testing, as it was these very methods that enabled us to detect a significant effect of medication withdrawal in the same patients. It is impossible to reconcile these findings with the conclusion reached by Jahanshahi et Curiously, almost all the CRT studies confined themselves to binary choices and none systematically varied number of stimulusresponse alternatives. Table 1 also shows for each separate experiment the "medication effect" (difference between performance on and off medication) for SRT, CRT, and MT. Altogether 11 estimates of SRT and MT are available and 10 of CRT. The proportion of these attaining statistical significance was 25% (SRT), 40% (CRT) and 73% (MT). Strangely, there is no correlation between the magnitude of the effects and their significance nor between the numbers of patients studied and the significance of the effects. 14 The interquartile range of the remainder is 20-50 ms and that of the MT values is 50-76 ms. Whereas comparisons across studies that differ as much as these in their design and in the nature of the tasks are clearly hazardous, it seems worth remarking that nothing in these data supports a general distinction between the sensitivity of SRT and CRT to dopaminergic manipulations.
Two studies9-12 stand apart, both because of the nature of the response required, a wrist rotation task, and the manner of manipulating state of medication (three levels of levodopa perfusion). Most of the remainder used manual keying responses combined with overnight withdrawal of all dopaminergic medication followed by morning testing, restoration of medication, and retesting. Obvious problems with such a simple, within group uncounterbalanced design are (a) the confounding of true effects of medication with effects due to retesting itself, and (b) the lack of a normative baseline allowing the separate assessment of the extent to which optimum medication fully restores normal performance. In a variant of this design, Jahanshahi et al 4 delayed retesting for several months, thus adding a fresh problem-namely, (c): the possible confusion of medication effects with an overall change in the patient's state.
In general, designs employing a between group comparison avoid the problems of retesting at the cost of introducing possible confusion of drug effects with inherent differences between the groups. Standard methods of minimising this problem involve prior matching of groups or, when the number of subjects is sufficiently large, random allocation to groups. Conversely, by electing to compare a de novo group of patients with Parkinson's disease with a stable medicated group, Jordan et al l' built into their study the likelihood of confounding, to the extent that characteristics other than treatment set apart Turning to outcome, only a minority of the studies yielded significant medication effects. Of these, the CRT effect reported by Rafal et al5 seems anomalously large. They required patients with Parkinson's disease to "move a heavy lever either to the left or right in response to a peripheral cue". The very large facilitatory effect of medication they obtained contrasts not only with findings in the rest of the literature but also with the non-significant effect that they reported for keypress SRT. On closer examination, it transpires that in the heavy lever task, the purported CRT measure of Rafal et al5 combines RT and MT. It seems distinctly possible, therefore, that much or all of their medication effect is attributable to time taken to execute the movement, itself. Incidentally, the provision of an 80% reliable response precue in this study also reduces the subject's response uncertainty before the imperative signal to a level that threatens to obscure the distinction between SRT and CRT.
Brown et al 15 found a significant impact of medication upon performance in a CRT task but this only obtained when using a direct spatial mapping of stimuli on to responses. In two variants, in which the responses were specified by symbolic stimuli, no effect of medication was observed. The study carried out by Montgomery and 
